Literature DB >> 19854554

Comparison of intravenous and intraosseous access by pre-hospital medical emergency personnel with and without CBRN protective equipment.

Lionel Lamhaut1, Christelle Dagron, Roxana Apriotesei, Jérome Gouvernaire, Caroline Elie, Jean-Sébastien Marx, Caroline Télion, Benoît Vivien, Pierre Carli.   

Abstract

INTRODUCTION: Rapid intravascular access is a prerequisite component of emergency care and resuscitation. Peripheral intravenous (IV) access is the first-choice for most of the medical or trauma patients, but may be delayed in emergency conditions because of various difficulties. Elsewhere, intraosseous (IO) access may now be easily performed with a new semi-automatic battery-powered IO-insertion device (EZ-IO. The aim of this study was to compare the overall time to establish IO infusion with the EZ-IO device and the equivalent time for peripheral IV infusion, performed by emergency personnel in standard (No-CBRN) and in chemical, biological, radiological, and nuclear (CBRN) protective equipment.
METHODS: Nine nurses and 16 physicians randomly performed 4 procedures on a training manikin: IV and IO access under No-CBRN conditions and IV and IO under CBRN conditions. The time for each infusion attempt included all the steps essential for a simulated safe clinical use of infusion.
RESULTS: Under No-CBRN conditions, the time to establish IO infusion was shorter than the equivalent IV time (50+/-9 vs 70+/-30s). Similarly, under CBRN conditions, the time for IO infusion was shorter than for IV infusion (65+/-17 vs 104+/-30s). The mean time saved by IO infusion over IV infusion was respectively 20+/-24s (P<0.001) and 39+/-20s (P<0.001) under No-CBRN and CBRN conditions.
CONCLUSION: The time to establish IO infusion was significantly shorter than that for peripheral IV infusion, under both No-CBRN and CBRN conditions. Further clinical studies are required to confirm that IO access would effectively save time over IV access in real pre-hospital emergency settings. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19854554     DOI: 10.1016/j.resuscitation.2009.09.011

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  7 in total

Review 1.  Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings.

Authors:  William J Brady; Summer Chavez; Michael Gottlieb; Stephen Y Liang; Brandon Carius; Alex Koyfman; Brit Long
Journal:  Am J Emerg Med       Date:  2022-04-27       Impact factor: 4.093

Review 2.  Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.

Authors:  Katharine Ker; Gavin Tansley; Deirdre Beecher; Anders Perner; Haleema Shakur; Tim Harris; Ian Roberts
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

3.  Resuscitation of the patient with suspected/confirmed COVID-19 when wearing personal protective equipment: A randomized multicenter crossover simulation trial.

Authors:  Marek Malysz; Marek Dabrowski; Bernd W Böttiger; Jacek Smereka; Klaudia Kulak; Agnieszka Szarpak; Milosz Jaguszewski; Krzysztof J Filipiak; Jerzy R Ladny; Kurt Ruetzler; Lukasz Szarpak
Journal:  Cardiol J       Date:  2020-05-18       Impact factor: 2.737

4.  Efficacy of the EZ-IO needle driver for out-of-hospital intraosseous access--a preliminary, observational, multicenter study.

Authors:  Richard Schalk; Uwe Schweigkofler; Gösta Lotz; Kai Zacharowski; Leo Latasch; Christian Byhahn
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-10-26       Impact factor: 2.953

5.  G-CSF Administration after the Intraosseous Infusion of Hypertonic Hydroxyethyl Starches Accelerating Wound Healing Combined with Hemorrhagic Shock.

Authors:  Hong Huang; Jiejie Liu; Haojie Hao; Chuan Tong; Dongdong Ti; Huiling Liu; Haijing Song; Chaoguang Jiang; Xiaobing Fu; Weidong Han
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

6.  Which intravascular access should we use in patients with suspected/confirmed COVID-19?

Authors:  Jacek Smereka; Lukasz Szarpak; Krzysztof J Filipiak; Milosz Jaguszewski; Jerzy R Ladny
Journal:  Resuscitation       Date:  2020-04-15       Impact factor: 5.262

Review 7.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.